• Similar articles
    ReutersReuters
    Sanofi trial failure halts work on breast cancer treatment amcenestrant
    Aug 17 2022. Sanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial potential in breast cancer, after a second trial failure dealt a major blow to the French healthcare company's…
    Sanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial potential in breast cancer, after a second trial failure dealt a major blow to the French healthcare company's…
    Reuters
    Breast cancer
    FTFT
    Become an FT subscriber to read: Sanofi drops experimental breast cancer drug after second trial fails
    Aug 17 2022. Keep abreast of significant corporate, financial and political developments around the world. Stay informed and spot emerging risks and opportunities with independent global reporting, expert commentary and analysis you can trust.
    Keep abreast of significant corporate, financial and political developments around the world. Stay informed and spot emerging risks and opportunities with independent global reporting, expert commentary and analysis you can trust.
    FT
    Similar
    HealthFT
    For Niven Narain, co-founder of biotech group Berg, “the concentration and the sexiness started in discovery but the digital health world has grown exponentially in the past year
    May 16 2020. Health: Pfizer and Sanofi that now have digital experts on their leadership teams. 18 months ago I couldn’t even tell you what a… ...breast cancer...
    Pfizer and Sanofi that now have digital experts on their leadership teams. 18 months ago I couldn’t even tell you what a… ...breast cancer...
    FT
    Similar
    Sanofi Faces First State Lawsuit Over NDMA
    Sep 24 2019. Health: Sanofi has been sued in Florida by a man claiming that the company’s heartburn drug Zantac caused him to develop breast cancer. The suit alleges that Sanofi sold Zantac knowing that it contained the suspected carcinogen N-…
    Sanofi has been sued in Florida by a man claiming that the company’s heartburn drug Zantac caused him to develop breast cancer. The suit alleges that Sanofi sold Zantac knowing that it contained the suspected carcinogen N-…
    Fdanews
    Similar

    About NewsOwner

    We are tracking and analysing news

    Add website

    Send us news sources you want us to cover

    Advertise

    Advertising and sponsored content

    Contact us

    Send us your comments or questions here

    Copyrights © 2016 - Scanmine Inc. / NewsOwner.com. This publication is automatically generated based on content updated from thousands of sources. All article content are © copyright of their respective owners. Third party content is collected from open sources only and selected, filtered and used by the creator of this publication similar to how third party content is posted by users in social media platforms or generated from search engines and in line with the U.S. "Fair Use Act" and similar laws in other countries allowing limited use of copyrighted material.